Functional imaging in Parkinson's disease and dementia with Lewy bodies

被引：19

作者：

Colloby, S ^{[1
]}

O'Brien, J ^{[1
]}

机构：

[1] Univ Newcastle Upon Tyne, Wolfson Res Ctr, Inst Ageing & Hlth, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England

来源：

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY | 2004年 / 17卷 / 03期

关键词：

Parkinson's disease; dementia; Lewy bodies;

D O I：

10.1177/0891988704267468

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Functional imaging modalities (positron emission tomography, single photon emission tomography, magnetic resonance spectroscopy, and functional magnetic resonance) allow aspects of regional cerebral function to be evaluated in various neuropsychiatric disorders. This review will summarize the use of such techniques in current imaging studies involving Parkinson's disease and dementia with Lewy bodies, with respect to assessing regional changes, using them in differential diagnosis, and monitoring disease progression and treatment effects.

引用

收藏

页码：158 / 163

页数：6

相关论文

共 60 条

[1] Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing [J].

Abe, Y ;

Kachi, T ;

Kato, T ;

Arahata, Y ;

Yamada, T ;

Washimi, Y ;

Iwai, K ;

Ito, K ;

Yanagisawa, N ;

Sobue, G .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (04) :419-422

[2] Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease [J].

Albin, RL ;

Minoshima, S ;

DAmato, CJ ;

Frey, KA ;

Kuhl, DA ;

Sima, AAF .

NEUROLOGY, 1996, 47 (02) :462-466

[3] Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease [J].

Antonini, A ;

De Notaris, R ;

Benti, R ;

De Gaspari, D ;

Pezzoli, G .

NEUROLOGICAL SCIENCES, 2001, 22 (01) :45-46

[4] [123I]β-CIT and SPECT in essential tremor and Parkinson's disease [J].

Asenbaum, S ;

Pirker, W ;

Angelberger, P ;

Bencsits, G ;

Pruckmayer, M ;

Brücke, T .

JOURNAL OF NEURAL TRANSMISSION, 1998, 105 (10-12) :1213-1228

[5]

Benamer HTS, 2000, MOVEMENT DISORD, V15, P503, DOI 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO

[6]

2-V

[7] Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET [J].

Berding, G ;

Odin, P ;

Brooks, DJ ;

Nikkhah, G ;

Matthies, C ;

Peschel, T ;

Shing, M ;

Kolbe, H ;

van den Hoff, J ;

Fricke, H ;

Dengler, R ;

Samii, M ;

Knapp, WH .

MOVEMENT DISORDERS, 2001, 16 (06) :1014-1022

[8] [I-123]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease [J].

Booij, J ;

Tissingh, G ;

Boer, GJ ;

Speelman, JD ;

Stoof, JC ;

Janssen, AGM ;

Wolters, EC ;

vanRoyen, EA .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (02) :133-140

[9]

Booij J, 1999, J NUCL MED, V40, P753

[10]

BRUCKE T, 1991, J CEREBR BLOOD F MET, V11, P220

← 1 2 3 4 5 6 →